Canada’s chief public health officer Dr. Theresa Tam discussed on Tuesday the processes that will be taken by Canadian health regulators after reports emerged of extremely rare blood clotting in some people who received the Johnson & Johnson COVID-19 vaccine in the United States. Johnson & Johnson has said it was aware of the rare reports of blood clots and was working with regulators to assess the data and provide relevant information.
Canada
Tam discusses process for Canadian health regulators following Johnson & Johnson COVID-19 vaccine reports
More Videos
-
Canada Post strike hits 1-week mark, calls for Ottawa to step in
-
‘Freedom Convoy’ organizer Pat King found guilty of mischief
-
Canada Post reports $315M pre-tax Q3 loss as strike continues
-
Blair says NASAM missiles ordered nearly 2 years ago have finally arrived in Ukraine
-
Trudeau blasts ‘criminals’ who leaked top-secret government information to media
-
Trudeau announces $108.5M Ontario school food program deal with province
You are viewing an Accelerated Mobile Webpage.
View Original Article